Abstract:Poor pharmacokinetics is one of the reasons for the withdrawal of drug candidates from clinical trials. There is an urgent need for investigating in vitro ADME (absorption, distribution, metabolism and excretion) properties and recognising unsuitable drug candidates as early as possible in the drug development process. Current throughput of in vitro ADME profiling is insufficient because effective new synthesis techniques, such as drug design in silico and combinatorial synthesis, have vastly increased the number of drug candidates. Assay technologies for larger sets of compounds than are currently feasible are critically needed. The first part of this work focused on the evaluation of cocktail strategy in studies of drug permeability and metabolic stability. N-in-one liquid chromatography-tandem mass spectrometry (LC/MS/MS) methods were developed and validated for the multiple component analysis of samples in cocktail experiments. Together, cocktail dosing and LC/MS/MS were found to form an effective tool for increasing throughput. First, cocktail dosing, i.e. the use of a mixture of many test compounds, was applied in permeability experiments with Caco-2 cell culture, which is a widely used in vitro model for small intestinal absorption. A cocktail of 7-10 reference compounds was successfully evaluated for standardization and routine testing of the performance of Caco-2 cell cultures. Secondly, cocktail strategy was used in metabolic stability studies of drugs with UGT isoenzymes, which are one of the most important phase II drug metabolizing enzymes. The study confirmed that the determination of intrinsic clearance (Clint) as a cocktail of seven substrates is possible. The LC/MS/MS methods that were developed were fast and reliable for the quantitative analysis of a heterogenous set of drugs from Caco-2 permeability experiments and the set of glucuronides from in vitro stability experiments. The performance of a new ionization technique, atmospheric pressure photoionization (APPI), was evaluated through comparison with electrospray ionization (ESI), where both techniques were used for the analysis of Caco-2 samples. Like ESI, also APPI proved to be a reliable technique for the analysis of Caco-2 samples and even more flexible than ESI because of the wider dynamic linear range. The second part of the experimental study focused on metabolite profiling. Different mass spectrometric instruments and commercially available software tools were investigated for profiling metabolites in urine and hepatocyte samples. All the instruments tested (triple quadrupole, quadrupole time-of-flight, ion trap) exhibited some good and some bad features in searching for and identifying of expected and non-expected metabolites. Although, current profiling software is helpful, it is still insufficient. Thus a time-consuming largely manual approach is still required for metabolite profiling from complex biological matrices.

Theory and Instrumentation of Mass Spectrometry and its Application to Drug Metabolism

Application of Mass Spectrometry for Metabolite Identification

Recent progress on the application of LC-MS-MS in drug metabolism

Liquid Chromatography-Mass Spectrometry in Studies of Drug Metabolism and Permeability

Analytical strategies for identifying drug metabolites

Applications of mass spectrometry in drug metabolism: 50 years of progress

Pharmaceutical Applications of Liquid Chromatography Coupled with Mass Spectrometry (LC/MS)

Advances in mass spectrometry applied to pharmaceutical metabolomics

Characterization of the Impact of Drug Metabolism on the Gas-Phase Structures of Drugs Using Ion Mobility-Mass Spectrometry.

Open-access liquid chromatography/mass spectrometry in a drug discovery environment.

A Brief Review on Liquid Chromatography-Mass Spectrometry/LCMS and its Application

LC-MS vs. GC-MS, Online Extraction Systems, Advantages of Technology for Drug Screening Assays

Current Applications of Liquid Chromatography/Mass Spectrometry in Pharmaceutical Discovery After a Decade of Innovation

Biochemical applications of mass spectrometry in pharmaceutical drug discovery

Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): The state of the art

Quantitative mass spectrometry methods for pharmaceutical analysis

State-of-the-art in liquid chromatography–mass spectrometry

Advances in high throughput LC/MS based metabolomics: A review

Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS

Evaluation of Data-Dependent MS/MS Acquisition Parameters for Non-Targeted Metabolomics and Molecular Networking of Environmental Samples: Focus on the Q Exactive Platform

Developing Liquid Chromatography Ion Mobility Mass Spectometry Techniques